{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:29:00Z","timestamp":1778707740282,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jns.2006.05.038","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T11:57:21Z","timestamp":1150459041000},"page":"48-52","source":"Crossref","is-referenced-by-count":24,"title":["Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease"],"prefix":"10.1016","volume":"248","author":[{"given":"Nicola","family":"Simola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier G.","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan Aghazadeh","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2006.05.038_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine\u2013dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2006.05.038_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410430415","article-title":"Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys","volume":"43","author":"Kanda","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2006.05.038_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(00)00745-7","article-title":"Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats","volume":"408","author":"Koga","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2006.05.038_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0006-8993(96)01036-0","article-title":"Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats","volume":"743","author":"Pollack","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2006.05.038_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-4886(03)00250-4","article-title":"A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease","volume":"184","author":"Bibbiani","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2006.05.038_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0014-4886(03)00316-9","article-title":"Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease","volume":"184","author":"Morelli","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2006.05.038_bib7","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1212\/01.WNL.0000095223.08711.48","article-title":"Translating A2A antagonist KW6002 from animal models to parkinsonian patients","volume":"61","author":"Chase","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.038_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","article-title":"Tremulous jaw movements in rats: a model of parkinsonian tremor","volume":"56","author":"Salamone","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2006.05.038_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-3057(96)00385-1","article-title":"Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions","volume":"57","author":"Finn","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jns.2006.05.038_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(97)00008-3","article-title":"Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs","volume":"322","author":"Cousins","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2006.05.038_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneumeth.2004.03.030","article-title":"The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis","volume":"140","author":"Ishiwari","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jns.2006.05.038_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-002-1247-3","article-title":"Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor","volume":"165","author":"Carlson","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2006.05.038_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(02)01818-6","article-title":"Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation","volume":"446","author":"Pinna","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2006.05.038_bib14","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.jns.2006.05.038_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2004.05.027","article-title":"Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions","volume":"189","author":"Simola","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2006.05.038_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/jm010924c","article-title":"7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility","volume":"45","author":"Baraldi","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.jns.2006.05.038_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(03)00178-5","article-title":"The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism","volume":"148","author":"Correa","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jns.2006.05.038_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1471-4159.1990.tb08817.x","article-title":"Both A1 and A2a purine receptors regulate striatal acetylcholine release","volume":"55","author":"Brown","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2006.05.038_bib19","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.66051882.x","article-title":"Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo","volume":"66","author":"Kurokawa","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2006.05.038_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.bjp.0703366","article-title":"Adenosine receptor expression and function in rat striatal cholinergic interneurons","volume":"130","author":"Preston","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2006.05.038_bib21","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/01.WNL.0000095216.89483.A2","article-title":"Modulation of glutamate release and excitotoxicity by adenosine A2A receptors","volume":"61","author":"Popoli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.05.038_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01352-9","article-title":"Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats","volume":"464","author":"Corsi","year":"2003","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T16:55:38Z","timestamp":1547571338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0022510X06002346"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2006.05.038","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}